Roche not yet meeting demand for molecular COVID-19 tests, says chairman
Share:
VIENNA (Reuters) - Swiss drugmaker Roche is unable to meet demand for molecular tests to identify active COVID-19 infections, its chairman told Swiss daily Tagesanzeiger."The demand exceeds our production," Christoph Franz was quoted as saying in Saturday's paper. The decision on where tests were shipped to depended, among other things, on infection rates and the availability of diagnostic equipment.Demand for its antibody tests, which determine whether people have ever been infected with the..